Experimental ocular tuberculosis in guinea pigs. 2009

Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
Doheny Eye Institute and Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

OBJECTIVE To develop an animal model of intraocular tuberculosis (TB) with features of pulmonary TB and extrapulmonary dissemination to the eye. METHODS Hartley strain guinea pigs were infected via an aerosol route with virulent Mycobacterium tuberculosis. One group of guinea pigs was infected with a relatively low bacterial inoculum and received no treatment. A second group of guinea pigs received high-dose infection and were treated with the first-line anti-TB drugs isoniazid, rifampin, and pyrazinamide. Development of ocular TB lesions was documented by histological analysis, acid-fast staining, and real-time polymerase chain reaction for M tuberculosis DNA. RESULTS Untreated guinea pigs developed pulmonary and extrapulmonary TB. Ocular TB, primarily involving the uvea, developed in 5 of 12 eyes (42%). Uveal granulomatous lesions showed the presence of acid-fast organisms and M tuberculosis DNA. In treated animals, none of the 8 eyes examined revealed the presence of acid-fast organisms; however, there was mild nongranulomatous uveitis in 4 eyes. CONCLUSIONS Mycobacterium tuberculosis delivered via aerosol to guinea pigs results in extrapulmonary dissemination to the eye. Of significance, intraocular changes in this model include granulomatous inflammation and the presence of acid-fast organisms, as seen in human cases of ocular TB. Clinical Relevance The guinea pig model may provide greater insight into the pathogenesis of intraocular TB and assist in the development of novel modalities to treat this global infectious disease.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011718 Pyrazinamide A pyrazine that is used therapeutically as an antitubercular agent. Tisamid
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
July 1954, Lekarske listy,
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
January 1955, Bullettino delle scienze mediche,
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
January 1982, Acta microbiologica Academiae Scientiarum Hungaricae,
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
January 1959, Archivum immunologiae et therapiae experimentalis,
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
May 1950, Diseases of the chest,
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
January 1979, Medicina,
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
August 1952, Tubercle,
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
January 1954, Annali dell'Istituto "Carlo Forlanini",
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
January 1954, Annali dell'Istituto "Carlo Forlanini",
Narsing A Rao, and Thomas A Albini, and Mirnalini Kumaradas, and Michael L Pinn, and Mostafa M Fraig, and Petros C Karakousis
January 1945, Problemy tuberkuleza,
Copied contents to your clipboard!